ArticleFrontiers in oncology2026

Efficacy, toxicity, and prognostic factors of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective cohort study.

Jin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.